Pfizer Loses Drawn-Out Battle Over Generic Neurontin
A federal judge in New Jersey has ruled in favor of five generic makers in their battle against drug giant Pfizer, Inc. over rights to the epilepsy drug Neurontin....To view the full article, register now.
Already a subscriber? Click here to view full article